Organism name | Tripterygium wilfordii |
---|---|
Genus | Tripterygium |
Family | Celastraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Tripterygium wilfordii |
---|---|
Linked NCBI taxonomy ID | 458696 |
Linked level | species |
Family in NCBI taxonomy | Celastraceae |
---|---|
ID | 4305 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00000659
![]() |
Medioresinol
/ (+)-Medioresinol |
CHEMBL376507
CHEMBL513023 |
2 / 1 / 1 | No. 38 | No. 21 |
![]() |
||
C00002631
![]() |
(+)-Lirioresinol B
/ (+)-Syringaresinol |
CHEMBL361362
CHEMBL402653 |
C042192
|
1 / 0 / 0 | No. 38 | No. 21 |
![]() |
|
C00046516
![]() |
Wilfornine E
|
CHEMBL450102
|
No. 43 |
![]() |
||||
C00046977
![]() |
Wilfordinine B
|
No. 43 |
![]() |
|||||
C00001987
![]() |
Wilfordin
|
CHEMBL449308
CHEMBL525628 |
No. 43 |
![]() |
||||
C00046976
![]() |
Wilfordinine A
|
CHEMBL2335702
|
No. 43 |
![]() |
||||
C00046846
![]() |
Peritassine A
/ (+)-Peritassine A |
CHEMBL1951082
|
No. 43 |
![]() |
||||
C00013107
![]() |
Alatusinine
/ (8a)-8-(Acetyloxy)-8-deoxo-26-hydroxyevonimine |
CHEMBL508998
CHEMBL501360 |
No. 43 |
![]() |
||||
C00013120
![]() |
Evonine
/ [8R-(8R*,9R*,10R*,11S*,12S*,13R*,14R*,15S*,18S*,19S*,20S*,21S*)]-10,13,14,21-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,18,19-decahydro-20-hydroxy-8,18,19,20-tetramethyl-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-5,17,22-trione |
CHEMBL449845
CHEMBL1996226 |
No. 43 |
![]() |
||||
C00013126
![]() |
Euonymin
/ Euonymine |
CHEMBL346753
CHEMBL503447 |
No. 43 |
![]() |
||||
C00046518
![]() |
Wilfornine G
|
CHEMBL502166
|
No. 43 |
![]() |
||||
C00046517
![]() |
Wilfornine F
|
CHEMBL524497
|
No. 43 |
![]() |
||||
C00013158
![]() |
Mayteine
/ [8R-(8R*,9R*,10R*,11S*,12S*,13R*,14R*,15S*,18S*,19S*,20S*,21S*,22R*)]-10,14,21,22-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-13-(benzoyloxy)-7,8,9,10,12,13,14,15,18,19-decahydro-20-hydroxy-8,18,19,20-tetramethyl-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-5,17-dione |
CHEMBL526919
CHEMBL1813072 |
C096143
|
No. 43 |
![]() |
|||
C00046978
![]() |
Wilfordinine C
|
No. 43 |
![]() |
|||||
C00013191
![]() |
Wilforidine
/ (8R,9R,10R,11S,12S,13R,14R,15S,21S,22S,23R)-[partial]-10,13,22,23-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-14,18,21-trihydroxy-8,18,21-trimethyl-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridine-5,17-dione |
CHEMBL504312
CHEMBL1950977 |
No. 43 |
![]() |
||||
C00013193
![]() |
Wilforine
/ (8alpha)-8-(Acetyloxy)-O2-benzoyl-O2-deacetyl-8-deoxoevonimine |
CHEMBL503312
CHEMBL502742 |
No. 43 |
![]() |
||||
C00013194
![]() |
Wilforzine
/ O6-Deacetylwilforine / ((8alpha)-8-(Acetyloxy)-O2-benzoyl-O2,O6-dideacetyl-8-deoxoevonimine |
No. 43 |
![]() |
|||||
C00046515
![]() |
Wilfornine D
|
No. 43 |
![]() |
|||||
C00046514
![]() |
Wilfornine C
|
CHEMBL509162
|
No. 43 |
![]() |
||||
C00046513
![]() |
Wilfornine B
|
CHEMBL525210
|
No. 43 |
![]() |
||||
C00039395
![]() |
Hyponine D
|
CHEMBL504037
|
No. 43 |
![]() |
||||
C00041008
![]() |
Hypoglaunine C
/ (+)-Hypoglaunine C |
CHEMBL501891
|
No. 43 |
![]() |
||||
C00041944
![]() |
Tripfordine A
|
CHEMBL504312
CHEMBL1950977 |
No. 43 |
![]() |
||||
C00041945
![]() |
Tripfordine B
|
CHEMBL453463
|
No. 43 |
![]() |
||||
C00046511
![]() |
Wilfordinine J
|
CHEMBL511075
|
No. 43 |
![]() |
||||
C00046512
![]() |
Wilfornine A
|
CHEMBL502989
|
No. 43 |
![]() |
||||
C00046510
![]() |
Wilfordinine I
|
CHEMBL508482
|
No. 43 |
![]() |
||||
C00041946
![]() |
Tripfordine C
|
CHEMBL505030
|
No. 43 |
![]() |
||||
C00013156
![]() |
Triptofordin D 1
/ [3R-(3alpha,5alpha,5aalpha,6alpha,9beta,9aalpha,10R*)]-10-(Acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-4-oxo-2H-3,9a-methano-1-benzoxepin-6-yl ester 3-phenyl-2-propenoic acid |
No. 168 |
![]() |
|||||
C00013148
![]() |
Triptofordin D 2
/ [3R-(3alpha,4alpha,5alpha,5aalpha,6alpha,9beta,9aalpha,10R*)]-4,10-bis(Acetyloxy)-5a-[(acetyloxy)methyl]-5-(benzoyloxy)octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6-yl ester 3-phenyl-2-propenoic acid |
No. 168 |
![]() |
|||||
C00049687
![]() |
(-)-17-Hydroxy-16alpha-kauran-19-oic acid
|
CHEMBL511892
CHEMBL481645 CHEMBL448617 CHEMBL456957 |
No. 203 | No. 41 |
![]() |
|||
C00049686
![]() |
(-)-16alpha-Hydroxykauran-19-oic acid
|
CHEMBL207260
CHEMBL480070 CHEMBL604095 CHEMBL1760135 |
C060419
|
1 / 0 / 0 | No. 203 | No. 41 |
![]() |
|
C00049689
![]() |
16alpha,19-Dihydroxy-ent-kaurane
|
CHEMBL1760128
|
No. 203 | No. 41 |
![]() |
|||
C00049759
![]() |
Triptobenzene N
/ (-)-Triptobenzene N |
CHEMBL444235
|
No. 355 |
![]() |
||||
C00049757
![]() |
Triptobenzene L
/ (+)-Triptobenzene L |
No. 359 | No. 40 |
![]() |
||||
C00049755
![]() |
Triptobenzene A
|
No. 760 |
![]() |
|||||
C00049758
![]() |
Triptobenzene M
/ (+)-Triptobenzene M |
No. 760 |
![]() |
|||||
C00002609
![]() |
Hinokiol
/ (+)-Hinokiol |
CHEMBL16901
|
26 / 24 / 20 | No. 761 | No. 23 |
![]() |
||
C00041947
![]() |
Tripterifordin
|
CHEMBL484043
|
C074970
|
No. 925 |
![]() |
|||
C00049760
![]() |
Triptoquinone C
|
No. 1436 |
![]() |
|||||
C00035883
![]() |
Triptoquinone B
|
No. 1436 |
![]() |
|||||
C00013189
![]() |
Triptofordin A
/ (+)-Triptofordin A / [3R-(3alpha,5beta,5aalpha,6alpha,9beta,9aalpha)]-6-(Benzoyloxy)octahydro-9-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-yl ester 3-phenyl-2-propenoic acid |
No. 1678 |
![]() |
|||||
C00002322
![]() |
Celabenzine
|
No. 2404 |
![]() |
|||||
C00049756
![]() |
Triptobenzene H
|
No. 2898 |
![]() |
|||||
C00035770
![]() |
Triptinin B
/ (+)-Triptinin B |
No. 2898 |
![]() |
|||||
C00003494
![]() |
Triptolide
|
CHEMBL463763
CHEMBL444360 |
C001899
|
6 / 13 / 18 | 20 / 15 | No. 3698 | No. 41 |
![]() |
C00003493
![]() |
Tripdiolide
|
CHEMBL486403
|
C001898
|
No. 3698 | No. 41 |
![]() |
||
C00035774
![]() |
Triptoquinone A
|
C100591
|
No. 4560 |
![]() |
||||
C00049761
![]() |
Triptotin B
/ (+)-Triptotin B |
No. 7621 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000659 | 1 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00049686 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00002609 | 1 / 1 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002609 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00003494 | 0 / 3 |
P06746 | DNA polymerase beta | Enzyme | C00002609 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002609 | 1 / 1 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00002609 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00003494 | 11 / 10 |
P37840 | Alpha-synuclein | Unclassified protein | C00002609 | 4 / 2 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00002609 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00002609 | 0 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00002609 | 1 / 1 |
P11387 | DNA topoisomerase 1 | Isomerase | C00002631 | 0 / 0 |
P34972 | Cannabinoid receptor 2 | Cannabinoid receptor | C00002609 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002609 | 2 / 2 |
P39748 | Flap endonuclease 1 | Enzyme | C00002609 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00002609 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00002609 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00003494 | 0 / 0 |
Q9Y2T6 | G-protein coupled receptor 55 | Lysophosphatidylinositol receptor | C00002609 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00002609 | 0 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00002609 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002609 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00002609 | 5 / 3 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00002609 | 0 / 0 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | C00003494 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000659 | 0 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002609 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00002609 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00002609 | 4 / 3 |
Q9GZV3 | High affinity choline transporter 1 | Choline Na-symporter | C00002609 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00002609 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002609 | 1 / 2 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00003494 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00003494 | 1 / 4 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00003494
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00003494
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00003494
|
941 | CD80, B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7 | CD80 molecule |
C00003494
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00003494
|
1082 | CGB, CGB3, CGB5, CGB7, CGB8, hCGB | chorionic gonadotropin, beta polypeptide |
C00003494
|
1843 | DUSP1, CL100, HVH1, MKP-1, MKP1, PTPN10 | dual specificity phosphatase 1 (EC:3.1.3.16 3.1.3.48) |
C00003494
|
2146 | EZH2, ENX-1, ENX1, EZH1, EZH2b, KMT6, KMT6A, WVS, WVS2 | enhancer of zeste homolog 2 (Drosophila) (EC:2.1.1.43) |
C00003494
|
3303 | HSPA1A, HSP70-1, HSP70-1A, HSP70I, HSP72, HSPA1 | heat shock 70kDa protein 1A |
C00003494
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00003494
|
3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
C00003494
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00003494
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00003494
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00003494
|
2908 | NR3C1, GCCR, GCR, GR, GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
C00003494
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00003494
|
6839 | SUV39H1, H3-K9-HMTase_1, KMT1A, MG44, SUV39H | suppressor of variegation 3-9 homolog 1 (Drosophila) (EC:2.1.1.43) |
C00003494
|
6863 | TAC1, Hs.2563, NK2, NKNA, NPK, TAC2 | tachykinin, precursor 1 |
C00003494
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00003494
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00003494
|
OMIM | preferred title | UniProt |
---|---|---|
%606641 | Body mass index; bmi |
P37231
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P84022
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#158580 | Neuronopathy, distal hereditary motor, type viia; hmn7a |
Q9GZV3
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P37231
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D058186 | Acute Kidney Injury |
C00003494
|
D000855 | Anorexia |
C00003494
|
D003967 | Diarrhea |
C00003494
|
D056486 | Drug-Induced Liver Injury |
C00003494
|
D005234 | Fatty Liver |
C00003494
|
D007249 | Inflammation |
C00003494
|
D007674 | Kidney Diseases |
C00003494
|
D015470 | Leukemia, Myeloid, Acute |
C00003494
|
D009101 | Multiple Myeloma |
C00003494
|
D009102 | Multiple Organ Failure |
C00003494
|
D009369 | Neoplasms |
C00003494
|
D010049 | Ovarian Diseases |
C00003494
|
D011014 | Pneumonia |
C00003494
|
D011507 | Proteinuria |
C00003494
|
D013163 | Splenomegaly |
C00003494
|